Search research articles
Contact Us
Filters
Showing results (51-60 of 138) with videos related to
Page
of 14
Sort By:
The Lancet. Oncology
|
August 1, 2012
Adjuvant nodal irradiation in melanoma
Muhammad Khattak, Martin Gore, James Larkin, et al.
World Journal of Surgical Oncology
|
March 24, 2016
Two cases of gallbladder metastasis from renal cell carcinoma and review of literature
Mafalda Costa Neves, Kyriakos Neofytou, Alexandros Giakoustidis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 25, 2015
Prognostic score for patients with advanced melanoma treated with ipilimumab
Stefan Diem, Benjamin Kasenda, Juan Martin-Liberal, et al.
Gynecologic Oncology
|
July 9, 2017
Erratum to "The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 405-413]
Melissa Matz, Michel P Coleman, Milena Sant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2007
A phase Ib and pharmacokinetic trial of patupilone combined with carboplatin in patients with advanced cancer
Martin Forster, Stan Kaye, Amit Oza, et al.
Frontiers in Oncology
|
November 3, 2012
Observation as a treatment strategy for advanced renal cell carcinoma-a call for prospective validation
Rosalie Fisher, Alexandra Pender, Kiruthikah Thillai, et al.
BMJ Case Reports
|
June 21, 2011
A report of succinate dehydrogenase B deficiency associated with metastatic papillary renal cell carcinoma: successful treatment with the multi-targeted tyrosine kinase inhibitor sunitinib
Mark Tuthill, Ravi Barod, Linda Pyle, et al.
Gynecologic Oncology
|
December 10, 2016
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)
Melissa Matz, Michel P Coleman, Milena Sant, et al.
Melanoma Research
|
December 20, 2015
Prognostic markers and tumour growth kinetics in melanoma patients progressing on vemurafenib
Heike Seifert, Rosalie Fisher, Juan Martin-Liberal, et al.
BMC Cancer
|
December 29, 2018
Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer
William P McGuire, Richard T Penson, Martin Gore, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 138) with videos related to
Sort By:
Page
of 14
The Lancet. Oncology
|
August 1, 2012
Adjuvant nodal irradiation in melanoma
Muhammad Khattak, Martin Gore, James Larkin, et al.
World Journal of Surgical Oncology
|
March 24, 2016
Two cases of gallbladder metastasis from renal cell carcinoma and review of literature
Mafalda Costa Neves, Kyriakos Neofytou, Alexandros Giakoustidis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 25, 2015
Prognostic score for patients with advanced melanoma treated with ipilimumab
Stefan Diem, Benjamin Kasenda, Juan Martin-Liberal, et al.
Gynecologic Oncology
|
July 9, 2017
Erratum to "The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 405-413]
Melissa Matz, Michel P Coleman, Milena Sant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2007
A phase Ib and pharmacokinetic trial of patupilone combined with carboplatin in patients with advanced cancer
Martin Forster, Stan Kaye, Amit Oza, et al.
Frontiers in Oncology
|
November 3, 2012
Observation as a treatment strategy for advanced renal cell carcinoma-a call for prospective validation
Rosalie Fisher, Alexandra Pender, Kiruthikah Thillai, et al.
BMJ Case Reports
|
June 21, 2011
A report of succinate dehydrogenase B deficiency associated with metastatic papillary renal cell carcinoma: successful treatment with the multi-targeted tyrosine kinase inhibitor sunitinib
Mark Tuthill, Ravi Barod, Linda Pyle, et al.
Gynecologic Oncology
|
December 10, 2016
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)
Melissa Matz, Michel P Coleman, Milena Sant, et al.
Melanoma Research
|
December 20, 2015
Prognostic markers and tumour growth kinetics in melanoma patients progressing on vemurafenib
Heike Seifert, Rosalie Fisher, Juan Martin-Liberal, et al.
BMC Cancer
|
December 29, 2018
Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer
William P McGuire, Richard T Penson, Martin Gore, et al.
Page
of 14